This document provides information about the 3rd Annual Medical Affairs Asia Summit taking place from August 26-29, 2014 in Singapore. The summit will feature over 85% new speakers and focus on advancing effective communication and collaboration with internal and external stakeholders. It will include keynote speeches, panel discussions, and workshops on topics like medical affairs strategies, stakeholder engagement, regulatory trends, and collaborating with marketing. The event is aimed at medical affairs professionals in the pharmaceutical and healthcare industries in Asia.

1. Produced by:
International Marketing Partner:
Media Partners:
www.pharmaconasia.com
Life
Sciences
IBC
LIFE SCIENCES
PARKROYAL on
Beach Road, Singapore
26-29 August 2014
Asia’s Longest Running Medical Affairs Strategy Forum
becomes even BIGGER...
Advancing Effective Communication and
Collaboration with Internal and External
Stakeholders
Supporting Associations:
Featuring Insights from: What’s New in 2014?
85% new speakers
Roundtable discussions for a relaxed
discussion among peers on key areas in
Medical Affairs
Dialogue between Medical Affairs and
Marketing to increase synergies and align
goals
Part of:
Pre-Conference Workshops: 26 August 2014 | Tuesday
A. Critical Evaluation of Scientific information and
Its Transformation into Meaningful Communication
B. Clinical and Medical Affairs Management: Lessons
from two Blockbusters in Ophthalmology
Post-Conference Workshops: 29 August 2014 | Friday
C. Cultivating A Sound Medical - Marketing
Partnership
D. Effective Engagement of Stakeholders in Chronic
Diseases
Dr Rene Rueckert
Global Program Medical
Director
Novartis
Switzerland
Dr Samuel Dryer
Chairman of the Board
Medical Science Liaison
Society, USA
Dr Kamlesh Patel
General Manager
Abbott Healthcare
India
Dr Elena Rizova
Vice President Asia Pacific
External Innovation,
Johnson & Johnson
Singapore
Dr Victoria Elegant
VicePresident,Medical,Clinical
and Regulatory Affairs
Baxter Healthcare
China
Dr Jacqueline Mao
Director,ASPACRegionalMedical
Lead Consumer Healthcare
Wyeth Pharmaceuticals
China
Sponsors:

2. REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com
CCOONFERENNFERENCE DCE DAAY OY ONENE
27 AUGUST 2014
Wednesday
8:50 Welcome from IBC Asia & Speed Networking
9:00 Chairman’s Welcome and Opening Remarks
Asia Pharmaceutical Market Outlook &
Regulatory Updates
9:10 Asia Pharmaceutical Investment Opportunities &
Development
• Where is the Asian pharmaceutical market heading towards?
• What are the investment and market opportunities available in
Asia?
• How are pharma companies in Asia coping with intensifying
competition and investment from overseas?
• Selecting the best business model, communication and operations
to maximize market share in Asia
• How regional integration has affected product launch and
marketing in the prescription and non-prescription market
Moderator:
Dr Joshi Venugopal, Managing Director, Singapore & Asian
Emerging Markets, Novartis
Panelists:
Jun Bao, Senior Vice President & Chief Business Officer,
Shenogen Pharma Group, China
Billy Sarvanantham Urudra, Chief Commercial Officer,
CCM Pharmaceuticals Sdn Bhd, Malaysia
Dr Narendra Vutla, Executive Vice President & Head, R&D –
Wellness, Oral Health & Site Operations, GSK Consumer
Healthcare, India
Carl Firth, CEO, Aslan Pharmaceuticals, Singapore
10:00 Asia’s Evolving Regulatory Landscape & Development
• Current initiatives and regulatory trends in Southeast Asia
• International models, frameworks and standards for Asia to adopt
• Regulatory trends and their impact on R&D investment
• Recent pharma marketing regulations changes and expecting
new guideline and compliance process under AEC
• Are pharma companies ready for the implementation and the
liberalization of health care services?
• Current regulatory challenges faced and how they can be tackled
• ASEAN harmonization and to what extent will it drive Asian
innovation?
Moderator:
Dr Samual Dryer, Chairman of the Board, Medical Science
Liaison Soceity, USA
Panelists:
Joy Chen, Director, Regulatory Affairs, Reckitt Benckiser,
Singapore
Ariel Valencia, Deputy Director, Food & Drugs Administration,
Department of Health, Philippines
Koichi Miyazaki, Senior Director, Regulatory Affairs Group, Asia
Development Department, Daiichi Sankyo, Japan
10:40 Morning Networking and Refreshment Break
Responding to Industry Changes through the
Medical Affairs Function
11:25 Welcome by Chairman
Dr Elena Rizova, Vice President Asia Pacific External Innovation,
Johnson & Johnson, Singapore
11:30 What Makes Medical Affairs Landscape Different inToday’s
Dynamic Cross-Functional Team?
• Trends and challenges from a Medical Affairs perspective
• Understanding medical practices and the unmet needs
• The right competencies that support cross functional teams of
therapeutic expertise, commercial, regulatory, R&D, legal,
compliance etc.
• Collaborations and setting expectations with different team
members
• Cultural differences across borders
Dr Chern Searn Lim, Country Head of Medical Affairs,
Pacific Rim, Shire, Singapore
12:10 Assessing the Medical Affairs Function: How to Hit Our KPI
• What are the roles, expectations and responsibilities of Asia’s MSLs?
• Structuring and coordinating medical affairs activities
• Strategies to be effective ambassadors across the scientific and
public health communities
• Measuring what matters through MSL metrics
Dr AjayTiku, RegionalMedicalDirector,CardiovascularDisease,
Asia Pacific, Middle East & Africa, Bristol Myers Squibb,
Singapore
12:50 Speed Networking
13:00 Networking Lunch
Dr Rene Rueckert, GlobalProgramMedicalDirector, Novartis,
Switzerland
Dr Anish Desai, Director Medical & Clinical Affairs,
Johnson & Johnson, India
14:00 Learning from the Evolution of Sales, Marketing and
Medical Affairs
• Evolution of our current selling model
• Emergence of Medical Affairs
• Bridging the divide
• Future outlook from a General Manager’s perspective
Dr Joshi Venugopal, Managing Director, Singapore & Asian
Emerging Markets, Novartis
Effective Medical Communications and
Digital Engagement of KOLs
14:40 MaximizeKOLEngagementthroughEffectiveMSLTraining
• Target, cultivate and develop relationships by delivering value
• Develop engagement programs that benefit stakeholders
• Achieve better positioning to improve trust and effective
communication
• Leverage external partnerships to share information and reach
internal and external stakeholders
Dr Samuel Dryer, Chairman of the Board, Medical Science
Liaison Society, USA
15:20 Afternoon Networking and Refreshment Break
15:40 Engagement and Development of Key Stakeholders
Through Strong Medical Communications
• Stakeholder identification
• Ideas to engage Stakeholders
• Successes & lessons learned for Asia
Senior Executive, Nucleus Holdings, Singapore
Innovative Talent Management
16:10 Combating Shortage ofTrained Professionals and Keeping
the Good Ones
• What is the extent of the problem and how is it being addressed
in Asia?
• Will successful models from the west work in the Asian context?
• How to prioritise resources to mitigate the lack of experienced
and well-trained medical affairs professionals
Dr Elena Rizova, Vice President Asia Pacific External Innovation,
Johnson & Johnson, Singapore
Interactive Round Table Discussions
16:30 Choose your preferred topic and discuss in a relaxed
roundtable setting with peers
• Medical Affairs for Oncology
Facilitator: Dr Anish Desai, DirectorMedical&ClinicalAffairs,
Johnson & Johnson, India___________________________________________________________________________________________________________________
• Medical Affairs for Medical Devices
Facilitator: Christine Lim, Senior Director, Johnson &
Johnson Medical Devices and Diagnostics, Singapore___________________________________________________________________________________________________________________
• Medical Affairs for Consumer Products
Facilitator: JacquelineMao, Director,ASPACRegionalMedical
Lead Consumer Healthcare, Wyeth Pharmaceuticals, China
17:30 Chairman’s Closing and End of Day One
VISIONARYKEYNOTEREGULATORYPANEL
VIPLUNCH
TABLES

3. REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com
CCOONFERENNFERENCE DCE DAAY TY TWWOO
28 AUGUST 2014
Thursday
KEYNOTE
8:50 Chairman’s Opening Remarks
Dr Samuel Dryer, Chairman of the Board, Medical Science
Liaison Society, USA
Internal Stakeholder Engagement, Collaboration
and Communication
9:00 Medical Affairs and Marketing Collaboration
• What are the common barriers between medical affairs and
marketing team?
• What medical affairs teams are looking for in aligning marketing
campaigns with business goals
• Best practices in internal and external communication to address
the correct needs of patients and prescribers
Dr Narendra Vutla, Executive Vice President & Head, R&D-
Wellness, Oral Health & Site Operations, GSK Consumer
Healthcare, India
9:40 Bridging the Gaps in Engaging with Internal Stakeholders
• Cross functional opportunities and challenges: where are the
conflict points?
• Where are the gaps that lead to misalignment between marketing
and medical affairs?
• Ensuring continuous feedback to boosting communication
• How do we link synergies and reconcile differences?
• Managing different priorities and expectations to create synergy
for win-win solutions
Moderator:
Dr Salman Bokhari, Managing Director, Sidrapex, Singapore
Panelists:
Dr AjayTiku, RegionalMedicalDirector,CardiovascularDisease,
Asia Pacific, Middle East & Africa, Bristol Myers Squibb,
Singapore
Dr Kamlesh Patel, General Manager, Medical, Abbott
Healthcare, India
Dr Narendra Vutla, Executive Vice President & Head, R&D –
Wellness, Oral Health & Site Operations, GSK Consumer
Healthcare, India
10:20 Morning Networking and Refreshment Break
Scientific Communication Strategies and
Clinical Development
11:00 Clinical Development and Medical Affairs: Realizing
Synergies for Successful Drugs
• Identify unmet medical need and develop integrated strategies
to address
• Clinical development resource planning- using synergies between
development and medical affairs
• Improve efficacy of clinical development and medical affair
strategies
• Effective life-cycle management strategy
Dr Rene Rueckert, Global Program Medical Director,
Novartis; Eyegnos Consulting, Switzerland
11:40 Keeping up with Complex Scientific and Medical
Information
• Transforming scientific data to useful, relevant information
• Improve quality and flow of information
• Skills needed to communicate complex, scientific data into useful
information to doctors and patients
• Communicating evidence-based value to stakeholders
Dr Kamlesh Patel, General Manager, Medical, Abbott
Healthcare, India
12:20 Reserve for Wiley
Martine Docking, Commercial Director, Asia Pacific, Wiley,
Singapore
12:50 Networking Lunch
14:00 Developing a Scientific Communication Plan and Customer
Oriented Strategy
• Develop and implement medical affairs/scientific communications
strategies and tactics
• Ensuring compliance while growing the MSL role
• Empowering the MSL involvement throughout the communication
plan
• Increasing product awareness by incorporating scientific
information sharing
• Addressing challenges to achieve set goals
Dr Anish Desai, Director Medical & Clinical Affairs,
Johnson & Johnson, India
14:40 Strengthening Medical Affairs through Investigator-
Initiated (IITs) Studies in Asia
• Including IITs to enhance the research process and involve
physicians
• Why investigator-led studies benefit doctors
• Strategies for successful IITs
• Compliance guidelines from IITs
Dr Victoria Elegant, Vice President, Medical, Clinical and
Regulatory Affairs, Baxter Healthcare, China
Strategies for Success while Keeping Compliant
15:20 Improve Relationships, Build Credibility and Motivate
KOLs
• Ensuring smooth communication and work relationships with
KOLs
• Optimizing KOL engagements through networking and value
exchanges
• Continually improving communication and coordination
• Establishing criteria to evaluate KOL engagement
Dr Aamir Shaikh, CEO, Assansa Health, India
16:00 Afternoon Networking and Refreshment Break
16:30 Effective Engagement of KOL in a Therapeutic Area
• Developing an innovative Medical Affairs team structure centered
on a particular therapeutic area
• Create and deliver therapeutic training programs to be used by
medical affairs
Dr Arun Gowda, Director, Phamax, Switzerland
The Future of Medical Affairs
17:10 Future Directions of the Medical Affairs Team
• Addressing talent management issues before looking at expanding
reach
• Where are the biggest opportunities for medical affairs
professionals?
• How do we approach common challenges faced in the region?
• Where should be the biggest investment to improve efficiencies?
Panelists:
Dr Anish Desai, Director Medical & Clinical Affairs,
Johnson & Johnson, India
DrVictoriaElegant, VicePresident,Medical,Clinical&Regulatory
Affairs, Baxter Healthcare, China
Dr Marion Munk, Research Fellow, Feinberg School of
Medicine, USA, Eyegnos Consulting, Switzerland
18:00 End of the 3rd Annual Medical Affairs Asia Summit
PANELDISCUSSIONS
PANELDISCUSSIONS

4. Dr Marion Munk, Ophthalmologist, Austria ; Eyegnos Consulting,
Switzerland
Dr Munk is an ophthalmologist with broad clinical interest, a focus on
clinical research in retina, age-related macular degeneration and cystoid
macular edema applying state of the art imaging as optical coherence
tomography and functional magnetic resonance tomography. She has
been involved in many global clinical trials, is a consultant to the pharmaceutical
industry and avid teacher, lecturer and presenter.
REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com
WORKSHOPS
OBJECTIVE:
To understand and to improve the ability to critically evaluate published
scientific evidence in developing meaningful scientific communication.
OUTLINE:
• Introduction into critical appraisal of scientific articles
• Questions to ask when critically appraising a research article- Steps in the
Evidence-Based Process
• Recognizing the strengths and weaknesses of the paper
• Common statistical presentations as well as sources of error and limitation-
Numerical language for clinical evidence
• Quantifying the risk of benefit/harm and interpretation of results related
to relevant theory
• Paraphrasing the significance of the paper in 3 or 4 sentences
ABOUT YOUR WORKSHOP LEADER:
Dr Kamlesh Patel, General Manager, Medical, Abbott Healthcare,
India
Dr Kamlesh Patel has over 12 years of experience in the pharmaceutical
industry. Prior to his current role as General Manager - Medical Affairs
and Head of Pharmacovigilance in Abbott HealthCare, India, he was
with Ranbaxy-Daichii Sankyo, Merck and Boehringer-Ingelheim.
Kamlesh played key roles in developing regulatory strategies to ensure faster
approvals and late phase clinical development programs as a part of KOL
engagement, launching innovative products and the formulation of consensus and
advocacy across multiple therapeutic areas. He is heavily involved in planning,
developing and implementing ethics, compliance and the core medico marketing
projects/initiatives across different therapeutic areas.
ABOUT YOUR WORKSHOP LEADERS:
Dr Rene Rueckert, Global Program Medical Director, Novartis,
Switzerland
Dr Rueckert is leading the global development in ophthalmology at
Novartis AG, Basel, Switzerland and is founder and CEO of eyegnos
consulting. He previously held senior positions at Novartis in marketing
and medical affairs in different areas. Previously, Dr Rueckert was the
Global Clinical Leader at Bayer AG in Berlin, where he established and built the
ophthalmology franchise and led the development of Eylea a now blockbuster
drug for retinal diseases, driving all aspects from preclinical to regulatory and
medical affairs to establishing clinical, GMA and brand teams. Before joining Bayer,
Dr Rueckert was academic lecturer and led a research group in Immunology. He is
author of many peer-reviewed publications, cited 2000-times and served as doctor
in Internal Medicine and Dermatology. He obtained his MD degree with highest
honors at the Charité Berlin, Germany. He holds a board certification in Biochemistry
and was trained in immunology and genetics at the Charité and at Yale University.
In Asia’s challenging health care and rapidly evolving pharmaceutical industry
environment, a sound Medical - Marketing partnership is vital, and often
demonstrably linked to‘success’.
Such a partnership will not occur by chance, and must be consciously cultivated.
Moreover, this partnership and its benefits must be perceived to exist by and
within the Medical - Marketing teams, the internal organization, and the external
stakeholders and customers. This half-day workshop will address the following
broad themes and related specific issues:
• Evolving Medical - Marketing Interaction – Cultivating a Sound Partnership
• Seeking Common Ground – Shared Vision, Strategic Thinking, Deliverables
• Effective Execution – Crafting Medical Development Plans Aligned with
Brand Plans
• Building and Nurturing an Effective Medical – Marketing Team - Leadership,
Trust, Communication, Accountability, and Results
ABOUT YOUR WORKSHOP LEADER:
Dr Aamir Shaikh, CEO, Assansa Health, India
Dr Aamir Shaikh, is the Founder of Assansa, a consultancy which
specializes in designing and delivering professional development
programs and customized learning experiences for the health care
industry and academia in the following core health care and
pharmaceutical industry domains: pharmaceutical medicine; medical /
clinical research, education and practice; and health care leadership
development. He was previously Director, Medical Affairs & Research for Pfizer India
where he nurtured, led and grew teams of Medical Affairs professionals across a
variety of medical affairs related domains in varied functional and therapeutic areas.
Current challenges to pharmaceutical companies in terms of managing
stakeholders are magnified in the emerging markets due to the local conditions.
Apart from the clinical stakeholders or physicians, there are other stakeholders
that are becoming critical to success in these markets. Payers, policy makers,
patient groups all have a stake in these markets and a well thought through
strategy is needed to effectively manage all of them.
However, some key questions remain:
• Why is it important to engage with local stakeholders?
• How do you engage the different stakeholders in a manner that there is a
benefit to everyone involved?
• What are the potential initiatives that can keep people engaged?
• How do you sustain and nurture this engagement to for a long term
engagement?
OUTLINE:
• The requirements of a scientific market access and the role of stakeholders
in it
• Identifying the key stakeholders for chronic disease
• CA(2)RE – A framework for engaging stakeholders
• Benefits of nurturing the engagement
• Case study: Effective engagement of stakeholders for policy change
ABOUT YOUR WORKSHOP LEADER:
Dr Arun Gowda
Dr Gowda is currently Director – FSRC (focus scientific research center)
a part of Phamax AG, where he is working towards developing unbiased
and comprehensive understanding of local issues through a scientific
framework to simplify and resolve issues in patients’ access to healthcare
in high-growth economies. Previously Arun was with Nokia as the Global
Product Lead, Health and Wellness managing the mHealth product for high-growth
economies.
Arun is a physician by training and has worked in various fields of the healthcare
sector. He has supported leading pharma and FMCG companies on work in
epidemiology, literature reviews, white papers & poster presentations, business &
clinical intelligence, market research, stakeholder engagement, brand positioning,
and digital marketing strategy.
Critical Evaluation of Scientific information and Its
Transformation into Meaningful Communication
Pre-Conference Workshop A
26 August 2014 (Tuesday) 9.00am – 12.30pm
Pre-Conference Workshop B
26 August 2014 (Tuesday) 1.30pm – 5.00pm
Cultivating a Sound Medical — Marketing Partnership
Post-Conference Workshop C
29 August 2014 (Friday) 9.00am – 12.30pm
Effective Engagement of Stakeholders in
Chronic Diseases
Post-Conference Workshop D
29 August 2014 (Friday) 1.30pm – 5.00pm
OBJECTIVE:
This workshop will present the clinical and the industry perspective on
developing breakthrough innovations in new indications and markets with
two Ophthalmology products as an example.
OUTLINE:
• Identification of unmet medical need and development of strategies to
address this need
• Combination of development and medical affair strategies
• Market preparation and entry strategy
• Lifecycle management
Clinical and Medical Affairs Management: Lessons
from two Blockbusters in Ophthalmology

5. REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com
IBC
LIFE SCIENCES
PARKROYAL on
Beach Road, Singapore
26-29 August 2014
Advancing Effective Communication and
Collaboration with International Stakeholders
COUNTRY:
■ Singapore 40%
■ Malaysia 10%
■ India 10%
■ US 10%
■ Europe 10%
■ China 5%
■ Indonesia 5%
■ Thailand 5%
■ Philippines 3%
■ Vietnam 2%
Who Should Attend:
With a market size of over $200 billion, Asia’s diverse pharma markets grow
even stronger with rising populations and incomes and the growing incidence
of chronic diseases. Medical Affairs has stepped up into becoming a central
function to ensure success in these markets by engaging KOLs with relevant
scientific information. Moreover, Medical Affairs teams need to collaborate
with R&D and understand the science, the business and the regulations. They
need to constantly think strategically and communicate effectively.
How can Medical Affairs teams be even more impactful
in enhancing your company’s scientific reputation?
How can you better communicate the value of your
products to KOLs and Healthcare professionals?
What makes a successful Medical Affairs team in Asia?
Get the answers and more at the 3rd MEDICAL AFFAIRS FORUM ASIA – the
region’s longest running strategy forum where leading medical affairs
professionals share best practices, discuss common issues and learn from
industry experts to enhance scientific reputation and better communicate the
value of products to KOLs.
Sponsorship Opportunities
Tailored sponsorship packages are available to meet your unique marketing & business
development requirements, enabling you to achieve the maximum ROI from your association
with this event.
For more information about placing your brand and profile top-of-mind to Medical Affairs
teams in Asia, contactYvonne Leong onTel: +65 6508 2489 / Yvonne.leong@ibcasia.com.sg
Why You Must Attend
This Year’s Event
Improve communication and relationships with
KOLs in key therapeutic areas to meet your KPIs
Be updated on the regulatory and cultural
landscapes in Asia’s key markets
Learn from industry thought leaders and peers
with global and regional experience in Medical
Affairs
Dialogue with internal stakeholders to better
communicate and align business strategies
Hear from experienced Medical Affairs Directors
on nurturing talents and building successful
Medical Affairs teams in Asia
INDUSTRY:
■ Pharma Companies 70%
■ CROs 13%
■ Medical Device 10%
■ Medical Communication/KOL Management Cost 5%
■ Staffing and Outsourcing companies 2%
“Speakers are really experienced, with practical
information”
~ Pfizer
“Very interactive with a case based learning approach”
~ Abbott Healthcare
Part of:

6. WHO SHOULD ATTEND?
• Head of Medical Affairs
• Medical Affairs Directors
• MSLs
• Chief Medical Officer
• Scientific Directors
• Medical Directors
• Medical and Scientific Affairs Executives
IBC
LIFE SCIENCES 4 Successful Events Under 1 Roof!
26 - 29 AUGUST 2014 | PARKROYAL ON BEACH ROAD, SINGAPORE
What is PharmaCon?
The Pharmaceutical Congress Asia (PharmaCon) is the leading annual event that brings together Government, pharmaceutical companies and
suppliers in Asia across:
4 Conferences 10 Workshops 4 Days of value-packed information Hours of networking opportunities
The dynamic program and networking platform aims to enable companies to develop strong partnerships, drive innovation and growth, as
well as winning products and services, in Asia’s growing pharmaceutical industry.
Asia’s premier Pharma R&D conference is designed
for professionals in the pharmaceutical R&D sector
to find out the latest investment, partnership and
collaboration opportunities, challenges facing drug
discovery and clinical development and how to
improve R&D innovation and productivity in Asia.
WHO SHOULD ATTEND?
Senior level professionals from:
Designed for regulatory professionals in the
pharmaceutical industry to come together to discuss
effective regulatory strategies for product access
into Asia and also globally as well as to gain clarity
on the complex and ever changing regulations in
the region.
WHO SHOULD ATTEND?
Professionals dealing with:
• Global/Regional Regulatory Affairs
• Regulatory Compliance
• Regulatory Submissions & Publishing
• Pharmacovigilance
• Market Access
Designed for senior executives from marketing in
prescription and consumer health sectors, the
conference pinpoints key success factors in
strategizing pricing, distribution, advertising &
promotion and product differentiation strategy in
this competitive market.This event is Asia’s one and
only platform to provide updated and in-depth
evaluation on marketing strategies in the
pharmaceutical industry.
WHO SHOULD ATTEND?
• CEO
• Chief Marketing Officer
• President/Managing Director/Vice
President of Asia
• Country Manager
• Regional Marketing Director
• Head of Corporate Planning
• Head of Commercialization
• Head of Marketing & Sales
• Head of Market Access
• Head of Business Development
• Head of Multi-Channel Marketing
• Head of Digital Marketing
• Head of Product Development
• Head of Packaging and Labeling
• Head of Procurement & Sourcing
• Head of Compliance
MEDICAL AFFAIRS FORUM ASIA is the region’s
longest running medical affairs forum where best
practices are shared and common issues with like-
minded peers are discussed. This event will bring
insights on how to be more effective in enhancing
your company’s scientific reputation and
communicating the value of your products.
• R&D
• Drug Discovery
• Clinical Trial and
Development
• Business Development
• Partnerships & Licensing
• Strategic Alliance
Management
• Strategy & Portfolio
Management
• Investment
• Mergers & Acquisitions
REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com

7. ENJOY SUBSTANTIAL SAVINGS WITH
OUR MULTIPLE BOOKING DISCOUNT!
REGISTER NOW! FAX BACK TO +65 6508 2407
HOTEL INFORMATION
DATA PROTECTION
PAYMENT TERMS
CANCELLATIONS / SUBSTITUTION
IMPORTANT NOTE
6 EASY WAYS TO REGISTER
Email
register@ibcasia.com.sg
Customer Service Hotline
+65 6508 2401
Fax
+65 6508 2407
Web
www.pharmaconasia.com
❑ Yes! I/We will attend the 3rd Annual Medical Affairs Forum Asia 2014 | 26 – 29 August 2014, ParkRoyal on Beach Road, Singapore
REGNO.200108203N
3RD ANNUAL MEDICAL AFFAIRS FORUM ASIA 2014
❑ I would like to purchase the conference presentations at SGD1000 + GST (SGD1070) per log in.
RESERVE YOUR PLACE TODAY!
CREDIT CARD PAYMENTS
The best way to pay by credit card is through our secure on-line registration process, simply log on to the website at
www.pharmaconasia.com and click “Register On-line”. If you would prefer to pay over the phone please complete the contact name and
details and our Customer Services Team will call within 24 hours to take payment. As we treat your credit card information in the strictest
confidence, please do not send payment details by email.
Credit card contact: Department:
Direct phone number: Email:
P46248
Payment Method (Please tick:) ❑ I enclose my bankers draft / cheque payable to IBC Asia (S) Pte Ltd
❑ I am paying by bank transfer (copy attached)
❑ Payment by Credit Card. (AMEX, VISA or MasterCard accepted)
Payment must be received 10 business days prior to the event. To
take advantage of discounts with an expiry date, registration and
payment must be received by the cut-off date.
• Payment by bankers draft or cheque in S$ or US$ should be
made in favour of “IBC Asia (S) Pte Ltd” and mailed to:
IBC Asia (S) Pte Ltd
c/o Informa Regional Business Services
111 Somerset Road, TripleOne Somerset #10-06
Singapore 238164
Attn: The Accounts Receivable Team
• Payment by bank transfer in S$ or US$ made payable to:
IBC Asia (S) Pte Ltd
A/C No.:147-059513-001 (S$)
A/C No.:260-457866-178 (US$)
The Hongkong and Shanghai Banking Corporation Limited
21 Collyer Quay, HSBC Building
Singapore 049320
Bank Swift Code: HSBCSGSG
Bank Code: 7232
• Payment by Credit Card (AMEX, VISA or MasterCard).
The best way to pay by credit card is through our secure portal
built into the website. To pay by phone please indicate the
contact name and details below and our Customer Services
Team will call within 24 hours to take payment. Please do not
send credit card information by email.
SAVE WITH THE
EARLY BIRD &
SPECIAL RATES!
The personal information entered during your registration/order, or
provided by you, will be held on a database and may be shared
with companies in the Informa Group in the UK and internationally.
Occasionally, your details may be obtained from or shared with
external companies who wish to communicate with you offers
related to your business activities. If you do not wish your details
to be used for this purpose, please contact our Database Department
at Email: database@ibcasia.com.sg, Tel: +65 6508 2400 or Fax:
+65 6508 2408.
Should you be unable to attend, a substitute delegate is welcome
at no extra charge. Cancellations must be received in writing at
least 10 business days before the start of the event, to receive a
refund less 10% processing fee per registration. The company
regrets that no refund will be made available for cancellation
notifications received less than 10 business days before the event.
Please quote the name of the delegate, event title and invoice
number on the advice when remitting payment. Bank charges are
to be deducted from participating organisations own accounts.
Please fax your payment details (copy of remittance advice, cheque
or draft to +65 6508 2407).
Attendance will only be permitted upon receipt of full payment.
Participants wishing to register at the door are responsible to ensure
all details are as published. IBC assumes no further liability or
obligation, beyond the refund of the paid registration fee, in the
event of postponement or cancellation by IBC.
MAIL the attached registration form with your
cheque to IBC Asia (S) Pte Ltd
c/o Informa Regional Business Services
111 Somerset Road, TripleOne Somerset
#10-06, Singapore 238164
Scan the QR Code
with your smartphone
and register today
Early Bird Rate
Register & pay on or
before 20 Jun 2014
FEE PER DELEGATE
Special Rate
Register & pay on or
before 18 Jul 2014
Group Rate
(3 or more delegates)
Normal Rate
Register & pay after
18 Jul 2014
❑ 2 Day Conference only
SGD 3,895 SGD 4,095 SGD 4,295 SGD 3,795❑ 4 Day Package: 2 Day Conference + All Workshops
GROUP BONUS – Register 3 Delegates from the same company and the 4th Delegate attends FREE!
SGD 2,595 SGD 2,795 SGD 2,995 SGD 2,495
• Multiple Bookings Discount pricing is applicable to groups of 3 or more delegates from the same organisation registering for the same event, at the same time. Fee stated
is the discounted price PER DELEGATE. Only one discount applies; either the early bird rate OR special rate OR group rate.
• All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel.
• Registration fees are subject to the prevailing government tax
Who is Head of your Department?
Who is Head of Training?
Company Information
Company Name:
Address:
Main Business/Activity:
Postal Code:
Please photocopy for additional delegates
FREE
GROUPDISCOUNT
Delegate 1 Details
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
Delegate 2 Details
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
Delegate 3 Details
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
Delegate 4 Details
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
❑ 3.5 Day Package: 2 Day Conference + 3 Workshops
❑ A ❑ B ❑ C ❑ D
SGD 3,295 SGD 3,495 SGD 3,695 SGD 3,195
PARKROYAL on Beach Road
7500 Beach Road, Singapore 199591
Hotel mainline: +65 6505 5666
Contact Person: Teo Hui Ling
Tel: +65 6505 5696
Email: teo.huiling@parkroyalhotels.com
SGD 3,595 SGD 3,795 SGD 3,995 SGD 3,495
❑ 3 Day Package: 2 Day Conference + 2 Workshops
❑ A ❑ B ❑ C ❑ D
❑ 2.5 Day Package: 2 Day Conference + 1 Workshop
❑ A ❑ B ❑ C ❑ D
SGD 2,995 SGD 3,195 SGD 3,395 SGD 2,895
4 Successful Events Under 1 Roof
180+ Attendees to Network With
4+ Days of Expert Knowledge Sharing
80+ Expert Pharmaceutical
Stakeholders & Key Decision Makers
15+ Interactive Formats to Get To Know
Your Peers & Customers
1 Joint Exhibition Area
Part of: